Immunai
immunai.comLocations
New York, NY, USA · Canal Street, New York, NY, USA
industry
Biotechnology
Size
51-200 employees
Stage
Series B
founded in
2019
Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Something looks off?Open jobs at Immunai
On-site & Remote
Job function
Seniority
Salary